PAM
ITOS

Panagora Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Panagora Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67,723
Closed -$691K – 1199
2024
Q3 		$691K Sell
67,723
-63,830
-49% -$974K ﹤0.01% 836
2024
Q2 		$1.95M Buy
131,553
+10,787
+9% +$155K 0.01% 529
2024
Q1 		$1.65M Sell
120,766
-3,745
-3% -$40.8K 0.01% 630
2023
Q4 		$1.36M Sell
124,511
-21,765
-15% -$216K 0.01% 700
2023
Q3 		$1.6M Buy
146,276
+25,237
+21% +$323K 0.01% 606
2023
Q2 		$1.6M Buy
121,039
+4,305
+4% +$61.4K 0.01% 618
2023
Q1 		$1.59M Buy
116,734
+66,303
+131% +$1.19M 0.01% 652
2022
Q4 		$985K Buy
50,431
+14,076
+39% +$275K 0.01% 892
2022
Q3 		$693K Buy
36,355
+14,965
+70% +$345K ﹤0.01% 1019
2022
Q2 		$441K Buy
+21,390
New +$508K ﹤0.01% 1197

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Panagora Asset Management's ITOS Position: Q4 2024 in Review

Panagora Asset Management sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 67,723 shares — an estimated $691K sold.

Panagora Asset Management first reported a position in ITOS in Q2 2022 and held it in 10 quarters. The position peaked at $1.95M in Q2 2024. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Panagora Asset Management reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Panagora Asset Management sold 67,723 iTeos Therapeutics shares in Q4 2024, an estimated $691K.
  • Panagora Asset Management first reported a position in iTeos Therapeutics in Q2 2022 and held it in 10 quarters.
  • Panagora Asset Management's iTeos Therapeutics position peaked at $1.95M in Q2 2024.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Panagora Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.